Ginkgo Bioworks Holdings, Inc. (DNA) NYSE
9.22
+0.08000027(+0.88%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
9.22
+0.08000027(+0.88%)
Currency In USD
Address
27 Drydock Avenue
Boston, MA 02210
United States of America (the)
Phone
877 422 5362
Sector
Healthcare
Industry
Biotechnology
Employees
834
First IPO Date
April 19, 2021
| Name | Title | Pay | Year Born |
| Jason Kelly | Co-Founder, Co-COO, CEO & Director | 255,000 | 1981 |
| Reshma Shetty | Co-Founder, President & Director | 255,000 | 1981 |
| Steven Coen | Chief Financial Officer | 438,692 | 1966 |
| Jennifer Wipf | Co-Chief Operating Officer | 0 | N/A |
| Karen Tepichin | General Counsel & Secretary | 0 | N/A |
| Samantha Sutton | Head of People | 0 | N/A |
| Bartholomew Canton | Co-Founder & CTO | 0 | N/A |
| Brian O'sullivan | Head of Commercial | 0 | N/A |
| Austin Che | Co-Founder & Head of Strategy | 0 | N/A |
| Daniel Marshall | Senior Manager of Communications & Ownership | 0 | N/A |
| Thomas Knight Jr. | Founder | 0 | N/A |
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.